Skip to main content

Animations

MJFF Publications

4231 - 4240 of 6466 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2024
  • 2019
  • 2019
  • 2019
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13121711
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2024/5580870
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-65010-7
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09633-9
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0080-x
    Citation Count: 161
  • Summary Details
    OPEN
    Title: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-019-01993-2
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00748-5
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Targeted co-expression networks for the study of traits
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-67329-7
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2024.05.017
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline
    Journal Name: BMJ Mental Health
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjment-2024-301062
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.